Macular Edema, Cystoid
11
0
0
9
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
9.1%
1 terminated out of 11 trials
90.0%
+3.5% vs benchmark
36%
4 trials in Phase 3/4
33%
3 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (11)
Intraretinal Cystoid Changes After Vitrectomy With Membrane Peeling
Influence of Diabetes Control on Treatment of Diabetic Macular Edema With Ranibizumab
The Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study
Dexamethasone Intravitreal Implant in Retinal Vein Occlusion
Effect of Prophylactic Ketorolac on CME After Cataract Surgery
Intraoperative Dexamethasone Implant Improves Outcome of Cataract Surgery With Diabetic Macular Edema
A Study of Denufosol Tetrasodium Intravitreal Injection in Subjects With Post Cataract Extraction Macular Edema
Effect of Intravitreal Long Acting Dexamethasone Implant, Ozurdex in Patients With Diabetic Macular Edema
Randomized Trial of Acetazolamide for Uveitis-Associated Cystoid Macular Edema
Steroid Injections vs. Standard Treatment for Macular Edema Due to Retinal Blood Vessel Blockage
Vascular Endothelial Growth Factor (VEGF) in Uveitis